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Fever 37 
Bloodstream infections (BC+) 9 
Use of vancomycin (VAN)/ 231 
amphotericin B (AMB) 4 
Days on antibiotics, mean (*SD) 14 (+-9) 
No. of readmissions at D+60 9 
Death 2 
No IC 
fn=43) P 
35 0.77 
6 0.57 
181 0.391 
4 0.99 
12 (a5) 0.51 
4 0.09 
1 0.99 
Conclusion: Keeping a previously placed IC did not 
seem to increase morbidity in this population of APSCT 
recipients. 
Analysis of risk factors for aerobic gram negative 
bacilli (AGNB) bacteremia (B) in bematopoietic stem 
cell transplant (HSCT) recipients (R): is there a high 
risk population? 
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Aim: Identification in HSCT R of a high risk population 
to develop AGNB B, who may benefit from anti- 
microbial preemptive therapy. 
Material and methods: A retrospective study conducted 
from January 1997 to December 2001; 258 HSCT R were 
included from the beginning of chemotherapy until 
neutropenia was resolved. We studied 231 febrile 
episodes, excluding B due to other microorganisms : 35 
with and 196 without B, which were evaluated analyzing 
age, sex, underlying disease, type of HSCT, grade of oral 
and gastrointestinal(G1) mucositis, abdominal and/or 
anal clinical site of infection, ICU requirement, and 
procedure-related mortality(PRM). 
Results: The prevalence of B was 13.5% (35/258). We 
found significant differences in : grade of GI mucositis 
manifested by diarrhea ~100Oml/day: 13/35 vs. 37/196, 
p=O.O02, RR=2.14, IC95%=1.16-3.94; abdominal/anal 
clinical site: 12/35 vs. 12/196,p=O.OOl,RR=4.50, IC 95% 
2.58-7.84; ICU requirement: 14/35 vs. 291196, p=O.OOl, 
RR=2.91, IC95% =1.62-5.26. The presence of diarrhea 
2 lOOOml/day, predicted B due to AGNB with sensitivity 
(S)=37% and specificity(Sp)=81% with a positive pre- 
dictive value (PPV) =25 % and negative predictive value 
(NPV)=87%; the presence of abdominal/anal site pre- 
dictedB withS=34%,Sp=93%,PPV=46% andNPV= 
88%. 
VRE infections have become a significant cause of 
morbidity and mortality among pt undergoing OLT. 
However, it is not known if VRE colonization pre-OLT 
is associated with worse outcomes. All adult pt listed for 
OLT at the University of Michigan from 1100 to 3102 
were eligible for study. Underlying illness, antimicrobial 
use, hospital stay, severity of liver disease, and other 
clinical data were gathered; rectal swabs for VRE were 
done at 4-6 month intervals pre-OLT. VRE cultures 
were repeated prior to transplant and every 5 days 
during the post-OLT hospitalization. Intra-operative 
bile cultures for VRE were obtained at OLT. Pt were 
followed for 2 months post-OLT to assess outcomes. 
Among 360 pt in the study, 42 (12%) were colonized 
with VRE prior to OLT. Of these 42, 64% were men; 
hepatitis C was the most common underlying diagnosis 
(26 %), and 12% had received a prior OLT. Colonized 
pt spent a mean of 14?14 days in hospital and received 
a mean of 46+-68 days of antimicrobial therapy during 
the previous 6 months. Of the 42 colonized pt, 11 died 
prior to OLT, 16 remain on the waiting list, 15 underwent 
OLT. Among these 15, 3 developed VRE-related 
infections post-OLT and 2 pt died, 1 secondary to VRE 
sepsis and endocarditis. 89 pt who were not colonized 
with VRE received an OLT; 9 (10%) died and 16 (18%) 
became colonized with VRE prior to discharge from 
hospital. Two of the 16 developed serious VRE-related 
infections that contributed to their deaths. 
VRE colonization is prevalent among pt awaiting 
OLT. Among 15 VRE colonized pt undergoing OLT, 3 
developed VRE-related infections; 2 of 16 pt who 
acquired VRE post-OLT developed VRE-related 
infections. VRE colonization prior to OLT does not 
appear to increase mortality. 
Comments: (1) The presence of diarrhea z lOOOml/day 
increased B risk by two times and was predictive in 1 of 
Viral complications after renal allotransplantation 
5 episodes of fever with high NPV. (2) The presence of 
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abdominal/anal site of infection increased the risk of B 
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4.5 times and was predicted in one of every two episodes 
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of fever ( PPV 46%). (3) B due to AGNB increased ICU 
requirements nearly 3 times and doubled the risk of 
mortality-related procedure. 
Conclusion: We propose the use of empirical antibiotic 
preemptive therapy in neutropenic HSCT R with 
diarrhea 2 lOOOml/day or with abdominal/anal clinical 
site of infection, despite the presence of fever. 
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